December 10, 2021

Key Takeaways from the 4th Annual NASH Roundtable™ Virtual Forum Read More »

November 30, 2021

ProSciento Becomes a California-Wide Sponsor of JDRF’s One Walks Read More »


View Recent Webinar


December 1, 2021

Community-Based Participatory Research Leads to Recruitment and Retention of NASH Subjects with Hispanic Background Read More »

November 20, 2021

A first in human, single ascending dose study to assess the safety and tolerability, pharmacokinetics, and pharmacodynamics of AB101 in subjects with type 1 diabetes Read More »

February 3, 2021

Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients. Read More »

Stay Connected

Would you like to receive updates from ProSciento?